Dental Practice Transaction Intelligence: The CoStar That 200,000 Dentists Don't Have
An estimated 10,000 dental practices change hands every year in the United States, and the sellers have no comparable sales database. DSOs backed by private equity buy hundreds of practices annually with dedicated M&A teams, proprietary comp databases, and EBITDA playbooks refined over thousands of transactions. The dentist selling once in a lifetime gets a broker referral from a colleague, a valuation based on a rule of thumb, and an unsolicited offer engineered to leave 20 to 40 percent of the practice's value on the table.
The Problem
The American Dental Association counted 202,485 professionally active dentists in the United States as of 2024. Of those, 34.2 percent are 55 or older: 18.7 percent between 55 and 64, and 15.5 percent past 65. The average dentist now retires at 68.7, according to ADA Health Policy Institute data released in early 2026, up from 64.7 in 2001. A 2019 ADA estimate projected that at least 100,000 dental practices would change hands between 2020 and 2030, a figure that DSO executives at a January 2025 Becker's forum suggested the industry would hit by 2026 or 2027, two to three years ahead of schedule. That pace implies roughly 10,000 to 12,000 practice transitions per year, each one a transaction worth $500,000 to $5 million depending on collections, payer mix, and location.
The seller in nearly every one of these transactions faces a structural information disadvantage so severe that it would be scandalous in any other asset class. When a homeowner sells a house, they open Zillow and see every comparable sale within a mile radius for the past five years, down to the price per square foot and the days on market. When a commercial real estate investor sells an office building, they pull CoStar and see cap rates, price per square foot, vacancy rates, and recent transaction comps across every submarket in the country. When a dentist sells the practice they built over 30 years, they get a broker's opinion of value based on a percentage-of-collections rule of thumb, a phone call to two colleagues who sold recently, and possibly a formal appraisal that costs $5,000 to $15,000 and arrives four to eight weeks later.
There is no centralized, anonymized database of dental practice transaction comps in the United States. Not from the ADA, not from any broker network, not from any data company. The closest analogues are fragmented: AFTCO, the largest dental-specific transition firm, has internal records from its own deals but does not publish aggregated benchmarks. Henry Schein Practice Transitions and ADS Transitions maintain proprietary deal data. Regional brokers work from personal networks. None of these data sets are accessible to the selling dentist, and none are cross-referenced against each other. The result is a market where the buyer class (DSOs and PE firms) has order-of-magnitude better information than the seller class (individual dentists), and that asymmetry is worth billions of dollars in aggregate value transfer every year.
Market Size
TAM calculation: The U.S. dental services market generates approximately $181 billion in annual revenue across roughly 130,000 dental practices (ADA estimate). The DSO market alone reached an estimated $44.7 billion in 2025, growing at 17.9 percent CAGR toward a projected $196.5 billion by 2034 (Benesch Dental/DSO Intelligence, citing Globe Newswire and ADA data). With 10,000 to 12,000 practice transitions per year at an average transaction value of approximately $1.2 million (the midpoint for a general practice doing $800,000 to $1.5 million in collections), total annual transaction volume is $12 to $14.4 billion.
Transaction intelligence products in comparable professional-services M&A verticals (accounting firms, veterinary practices, physician groups) charge the buyer side $2,000 to $10,000 per year for benchmarking access and the seller side $500 to $2,000 per year for valuation tools. At 4,500 subscribing DSO locations and PE-backed groups (the buyer side, paying an average of $4,800/year for comp data and deal flow intelligence) plus 8,000 dentist subscribers on the sell side (paying $1,200/year for valuation benchmarking and market positioning), the platform TAM is $31.2 million in recurring revenue. Add a transaction-completion fee of 0.15 percent on facilitated deals (conservative against the 5-10 percent broker commissions currently standard), applied to 2,000 annual deals at $1.2 million average, and the transaction layer adds $3.6 million. Total addressable: $34.8 million ARR.
The more interesting SAM expansion comes from adjacent verticals with identical dynamics. Veterinary practices face the same PE-backed consolidation wave (Mars/VCA, National Veterinary Associates, Pathway Vet Alliance) with the same information asymmetry. Optometry practices are seeing early-stage DSO-style consolidation. Dermatology, orthopedics, and other physician specialties are all mid-consolidation. A platform that solves the comp-data problem for dental could expand horizontally across healthcare practice M&A, a combined market exceeding $100 million ARR.
The Product
A transaction intelligence platform for dental practice M&A that combines anonymized deal data, practice financial benchmarking, and real-time DSO demand signals into a single decision-support system. Two distinct interfaces serve the two sides of the market:
- Seller dashboard (DentistComp): A dentist considering a sale enters their practice financials (collections, overhead categories, patient counts, payer mix, procedure mix) and receives an instant, anonymized benchmark against comparable practices that have sold in their state and metro area within the past 36 months. The output is not a single number but a range: "Practices in the San Francisco Bay Area with $1.1M to $1.4M in collections and 18-22 percent hygiene production sell for 72 to 81 percent of collections in private sales, or 4.2x to 5.8x adjusted EBITDA in DSO transactions." That range is constructed from real transaction data contributed by participating brokers, transition firms, and verified self-reported sales. The dashboard also flags specific financial metrics that move multiples: hygiene-to-total production ratio, new patient flow per month, doctor-dependency (percentage of production from the owner versus associates), and payer mix (Medicaid percentage above 25 percent depresses DSO demand). Each metric shows where the practice falls relative to the comp set, with directional guidance on what to improve before listing
- Buyer intelligence suite (DSOScope): DSOs, PE firms, and their advisors get aggregated market data on practice availability, pricing trends by geography and practice profile, and competitive intelligence on which markets are heating up (more DSO inquiries per available practice) or cooling down. The unique data asset is anonymized demand-side signal: how many unsolicited LOIs a practice in a given profile has received, the spread between initial offers and closed prices, and the average timeline from LOI to close. This data does not exist anywhere in aggregated form today. For DSOs, the value proposition is not finding practices to buy (they have deal teams for that) but pricing them efficiently and benchmarking their own deal economics against the market
- EBITDA adjustment analyzer: The single most consequential number in a DSO acquisition is the adjusted EBITDA, and the single most common way sellers lose value is through under-counting legitimate add-backs. A widely circulated analysis by McLaren and Associates documented a case where a dentist with an unsolicited offer of $6.8 million at a 7x multiple closed at $9 million after proper EBITDA adjustments and competitive bidding, a $2.2 million difference on the same practice. The adjustment analyzer walks sellers through every standard add-back category (owner compensation normalization, one-time expenses, discretionary spending, above-market rent to self-owned real estate, family member compensation) with benchmarks for what acquirers typically accept, flagging where the seller's initial EBITDA is likely understated
Unit Economics
| Metric | Value |
|---|---|
| Seller subscription (annual valuation benchmarking) | $99/month ($1,188/year) |
| Buyer subscription (DSO/PE comp data + demand signals) | $399/month ($4,788/year) |
| Transaction completion fee (facilitated deals) | 0.15% of deal value |
| Data contribution incentive (broker/transition firm) | Free platform access + revenue share |
| Customer acquisition cost (seller side) | $680 |
| Customer acquisition cost (buyer side) | $2,400 |
| Expected seller LTV (18-month avg engagement pre-sale) | $1,782 |
| Expected buyer LTV (36-month retention, enterprise) | $14,364 |
| Blended LTV:CAC ratio | 5.2:1 |
| Gross margin | 89% |
| Startup cost (18-month runway) | $3.2M |
| Break-even | 22 months |
Methodology note: The seller-side CAC of $680 reflects acquisition through dental association partnerships (ADA, state associations), continuing education sponsorships, and targeted digital marketing to dentists aged 55 and older through dental-specific publications like Dentaltown and Dental Economics. The buyer-side CAC of $2,400 reflects enterprise B2B sales to DSO corporate development teams, distributed across the 20 to 80 locations a typical mid-market DSO operates. Seller retention of 18 months reflects the typical timeline from "considering a sale" to closing; once a dentist sells, they churn, but the pipeline of 69,251 dentists aged 55 and older (ADA 2024 data: 34.2 percent of 202,485) refreshes annually as more dentists enter the pre-transition window. Buyer retention of 36 months is conservative against CoStar's 90 percent-plus annual retention in commercial real estate, where comp data becomes embedded in the underwriting workflow and switching costs are high.
Go-to-Market
Phase 1 (months 1-10): Solve the cold-start data problem. The platform is worthless without transaction comps, and transaction comps are privately held by brokers and transition firms. The play: recruit the top 15 dental practice brokers and transition firms (AFTCO, Henry Schein Practice Transitions, ADS Transitions, Professional Transition Strategies, and 11 regional firms that collectively handle an estimated 60 percent of brokered dental transactions) to contribute anonymized deal data in exchange for free access to the aggregated benchmark set. Each firm sees only its own data today. The platform gives each firm access to the full market picture for the first time, which is a genuine competitive advantage in pitching new listings. This is the exact model STR used to build the hotel industry's benchmarking standard: give every participant something they cannot get alone, and the network effect makes the data set unassailable. Simultaneously, launch a free practice valuation estimator (the "Zestimate for dental practices") that uses publicly available data (practice location, specialty, years in operation) to generate a rough valuation range, capturing email addresses and building the seller pipeline. The free tool is deliberately imprecise, and the paid tier adds transaction-comp precision.
Phase 2 (months 11-18): Monetize the sell side. Launch the $99/month seller subscription with real comp-backed valuation benchmarks for dentists in the top 20 metro areas (covering approximately 55 percent of U.S. dental practices by count). Integrate EBITDA adjustment analyzer. Begin outbound sales to DSO corporate development teams for the buyer subscription. Publish the first "Dental Practice Transaction Report" as a quarterly industry benchmark (free executive summary, paid full report), establishing the platform as the authoritative data source for dental M&A pricing. Present findings at the DEO Leadership Summit and ADA annual meeting.
Phase 3 (months 19-30): Expand to full national coverage. Launch transaction completion fees on deals that originate through the platform's buyer-seller matching. Build the veterinary practice module (identical architecture, different data set) to begin horizontal expansion. Approach dental lenders (Bank of America Practice Solutions, Provide, and specialty lenders) as distribution partners: integrate valuation benchmarks into the loan underwriting workflow so that every SBA 7(a) dental practice acquisition loan automatically references the platform's comp data. This is the CoStar playbook applied to dental: make the data so embedded in the transaction workflow that every participant assumes it exists.
Competitive Landscape
| Company | What It Does | Transaction Comps? | Pricing |
|---|---|---|---|
| AFTCO | Largest dental transition firm; brokerage + appraisals | Internal only; not available to non-clients | 5-7% commission |
| Henry Schein Practice Transitions | Practice brokerage + equipment bundle | Internal only; tied to equipment sales | 5-8% commission |
| ADS Transitions | Regional practice brokerage network | Internal only; fragmented by region | 6-10% commission |
| DentalPost | Job board for dental professionals | No: employment marketplace, not M&A | Subscription |
| ADA Practice Transitions | Practice listing marketplace from ADA | No: listings only, no closed-deal data | Free listings |
| PracticeFuel / BizBuySell | General business-for-sale marketplaces | Listing prices, not closed prices | Free / $60-300/mo |
| This startup | Transaction comp database + valuation benchmarking | Core product: anonymized closed-deal analytics | $99-399/mo |
The structural gap mirrors commercial real estate before CoStar consolidated the market in the 1990s. Every dental broker has their own deal records. No broker shares them, because the data is their competitive moat. But the moat is an illusion: the broker with the best data still has a fraction of the total market picture. An aggregated, anonymized dataset benefits every participant more than any individual dataset benefits its holder. CoStar proved this in commercial real estate and built a $35 billion company on it (NYSE: CSGP, market cap as of June 2026). STR proved it in hotels and was acquired by CoStar for $450 million. Nobody has proved it in dental practice M&A, because nobody has tried.
Why Now
Three forces are converging to make the next five years the critical window. First, the retirement wave is accelerating. The ADA's 2024 workforce data shows that dentist supply growth has flatlined: the profession added just 181 net dentists in 2024 (202,485 versus 202,304 in 2023), down from annual gains of 2,000 to 3,000 in the early 2010s. The cause is retirements outpacing new graduates. With 15.5 percent of active dentists (31,385 people) already past 65 and another 18.7 percent (37,865 people) between 55 and 64, the retirement pipeline is enormous. ADA data shows that a considerable share of dentists aged 60 and older have left the workforce since 2017, and the average retirement age has ticked down from its 2018 peak of 69.1 to 68.7 in 2024. Every one of these retirements is a potential practice sale, and the current pace suggests 10,000 to 12,000 per year for the next decade.
Second, DSO consolidation is shifting from quantity to sophistication in ways that make information asymmetry worse for sellers. Benesch's April 2026 DSO Intelligence report describes a market "evolving into a more disciplined, multi-model growth strategy" where DSOs combine affiliations, de novos, specialty partnerships, and retail-embedded growth. MB2 Dental, Heartland Dental, Beacon Oral Specialists, and PDS Health are all active acquirers with distinct playbooks. More than 25 percent of dentists within 10 years of graduation now work in DSO-affiliated practices (ADA data), meaning the buy-side is increasingly professionalized while the sell-side remains atomized. The selling dentist is not just facing an information deficit on pricing; they're facing an experience deficit on deal structure, earnout terms, holdback provisions, and joint venture equity splits that can move the effective value by 20 to 30 percent.
Third, practice ownership patterns are shifting in ways that compress the transition timeline. ADA Health Policy Institute data from June 2025 shows that only 21 percent of 2016-2020 dental school graduates own practices within three to seven years of graduation, compared with 63 to 70 percent of pre-2010 graduates at the same career stage. Ownership rates eventually converge at the 15-to-19-year mark, but the delayed entry means fewer independent owners building the long-tenure practices that traditionally commanded premium sale prices. As ownership concentrates in older cohorts and younger dentists opt for DSO employment, the pool of traditional buyer-to-buyer private sales shrinks, giving DSOs more negotiating power and making comp data even more critical for the independent seller trying to maximize value.
Original Contribution: Quantifying the Information Asymmetry Tax
A calculation nobody has published: DSO acquisition advisors consistently cite a 20 to 40 percent value gap between unrepresented and represented sellers. Dental Practice Insider's 2026 valuation data shows general practices selling for 65 to 85 percent of collections in private sales or 3.5x to 5.5x EBITDA in single-location DSO deals. Multi-location platforms command 5x to 8x. The range itself tells the story: a practice collecting $1.2 million annually is worth somewhere between $780,000 and $1,020,000 in a private sale, or between $210,000 and $330,000 in EBITDA (at typical 15-25 percent EBITDA margins) times 3.5 to 5.5, yielding $735,000 to $1,815,000 in a DSO deal. That spread, from $735,000 to $1,815,000, is a 2.5x range on the same underlying practice.
What drives where a practice lands in that range? Two factors the seller almost never benchmarks: adjusted EBITDA calculation and competitive bidding pressure. On EBITDA adjustments alone, the McLaren and Associates case study documents a practice where proper add-back identification moved EBITDA from approximately $970,000 to $1,285,000, a 32 percent increase, which at a 7x multiple translated to a $2.2 million value improvement. Extrapolate conservatively: if the median unrepresented seller leaves just 15 percent of adjusted EBITDA on the table, and the median DSO deal closes at 5x EBITDA on a practice generating $250,000 in true adjusted EBITDA, the information asymmetry costs the median seller $187,500 per transaction. At 3,000 to 4,000 DSO-acquired practices per year (roughly 30 to 40 percent of all transitions, based on DSO market share growth), the aggregate value transfer from unrepresented sellers to PE-backed DSOs is $562 million to $750 million annually.
That number has a wide confidence interval, and we should be honest about why. We don't know the actual distribution of representation rates among selling dentists, the actual median EBITDA understatement, or the actual number of DSO acquisitions per year (DSOs do not report deal counts publicly). But the directional claim holds up: a structurally uninformed seller class is transferring hundreds of millions of dollars per year in practice value to a structurally informed buyer class, and the primary mechanism is not fraud or coercion but simply the absence of comparable sales data that every other asset class takes for granted.
Limitations
This analysis relies on several estimates that deserve scrutiny. The "10,000 to 12,000 practice transitions per year" figure extrapolates from a 2019 ADA projection of 100,000 transitions over the decade, accelerated by DSO executives' qualitative assessment at a 2025 Becker's forum. The ADA has not published an updated count. The actual number could be lower if rising interest rates since 2022 have depressed acquisition activity (as Group Dentistry Now reported in late 2025) or higher if the retirement wave is accelerating faster than expected. Without a centralized transaction registry (which is precisely the product this startup proposes to build), nobody knows the real number.
The $181 billion total dental services market figure comes from IBISWorld industry estimates, which are themselves modeled rather than measured. The $44.7 billion DSO market size from Benesch's newsletter cites Globe Newswire, which aggregates market research reports of varying rigor. The 17.9 percent CAGR projection to $196.5 billion by 2034 may reflect the bullish end of industry forecasting rather than a reliable growth rate, particularly given the interest-rate headwinds to PE-backed acquisition activity.
The EBITDA add-back gap (15 to 32 percent of adjusted EBITDA left on the table by unrepresented sellers) is derived from a single, albeit detailed, case study and corroborated by qualitative broker assertions. A rigorous study would require access to hundreds of matched transactions (same practice profile, represented versus unrepresented), which does not exist in any public dataset. The $562 to $750 million aggregate value transfer calculation should be treated as a directional estimate, not a precise figure.
Strongest Counterargument
The most compelling case against this startup is that the data cold-start problem may be permanently unsolvable. Dental practice brokers are the gatekeepers of transaction data, and their business model depends on information asymmetry. AFTCO's competitive advantage is not its listing network (the ADA runs a free listing service) but its accumulated knowledge of what practices actually sell for in specific markets. If AFTCO contributes its data to an anonymized aggregation platform, it gives away the very asset that justifies its 5 to 7 percent commission. Why would any broker participate?
The STR analogy has a structural flaw when applied to dental practice M&A. STR succeeded in hotels because every hotel produces occupancy and revenue data every night, generating a continuous data stream that is useful only in aggregate, and because major hotel chains could mandate participation across thousands of properties. Dental practice sales happen once per practice per generation. The data is sparse (10,000 transactions per year across 50 states and hundreds of metro areas, yielding thin comp sets in most local markets), episodic (each data point is a one-time event), and deeply sensitive (a sold practice's financial details could affect the new owner's competitive position, staff negotiations, and payer contracts). The incentive to contribute data is weaker and the risk of contribution is higher than in hotels, commercial real estate, or any recurring-transaction market.
There is also a structural question about whether comp data actually changes outcomes for sellers. The residential real estate analogy suggests it does: Zillow's Zestimate demonstrably affected listing prices and seller expectations (a 2017 study in the Journal of Housing Economics found that Zestimates influenced both listing and sale prices). But dental practice transactions are not commodity transactions. Every practice is idiosyncratic in its patient base, location, staff, facility, technology, and owner personality, which makes "comparable" sales less comparable than in residential real estate. A practice collecting $1.2 million in San Jose with a Mandarin-speaking patient base and a fee-for-service payer mix is not meaningfully comparable to a practice collecting $1.2 million in San Jose with a PPO-dominant, English-speaking patient base, even though the comp database would group them together. The risk is that comp data gives sellers false confidence in a valuation range that doesn't actually apply to their specific practice, leading to either overpricing (stale listings) or underpricing (accepting a multiple that is "above average" but below what competitive bidding would produce).
The Bottom Line
The U.S. dental practice M&A market is a $12 to $14 billion annual transaction flow where one side has data and the other does not. Sixty-nine thousand dentists aged 55 and older are entering the pre-transition window, DSO consolidation is accelerating at 17.9 percent CAGR, and the information asymmetry between institutional buyers and individual sellers is worth hundreds of millions of dollars per year in aggregate value transfer. The data cold-start problem is real, the broker incentive alignment is tricky, and the thin-comp problem in small markets will limit precision. But the directional opportunity is clear: dental practice M&A is the last major professional-services transaction market without a comp database, and every year of opacity is another year where ten thousand dentists sell their life's work without knowing what it was actually worth.
What You Can Do
If you are a dentist aged 50 or older: get a formal practice valuation now, not when you are ready to sell. The $5,000 to $15,000 cost of an appraisal is trivial relative to the $187,000 to $2.2 million in value at risk from improper EBITDA adjustments and uncompetitive deal processes. Request appraisals from at least two independent firms (not the broker who wants to list your practice) and ask each to provide their adjusted EBITDA calculation with all add-backs itemized. Compare the two numbers. If they differ by more than 10 percent, the gap is the information asymmetry tax you are already paying. If you are a dental practice broker: recognize that aggregated comp data is coming to this market whether you contribute to it or not, and early contributors will shape the methodology and gain preferential access. The brokers who shared data with STR in 1985 built the standard that every hotel now relies on. The brokers who refused became irrelevant. If you are a DSO executive: a transparent comp market will raise seller expectations and compress your acquisition multiples, but it will also reduce deal-cycle times, lower advisory costs, and eliminate the reputational risk of the "predatory offer" narrative that is increasingly common in dental media. The net effect on your portfolio company's IRR may be positive.
Related
📰 Franchise Unit Economics Intelligence — the comp-data problem for franchise resales, another opaque market where buyers and sellers have asymmetric information
📰 Veterinary Insurance Claims Automation — adjacent vertical with identical PE-backed consolidation dynamics and fragmented practice ownership
📰 Equipment Rental Rate Intelligence SaaS — the STR benchmarking model applied to construction equipment, another industry with no centralized transaction data